Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
10-day decitabine with venetoclax for newly diagnosed int... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
0
Authors
Courtney DiNardo
38 more
Courtney DiNardo
•
Nicholas Short
36 more
•
Marina Konopleva
Published
September 6, 2020
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Haematology
Topics
Physics
Biochemistry
Chemistry
Medicine
Cancer Oncology
Show all topics
DOI
10.1016/s2352-3026(20)30210-6
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Haematology
Topics
Physics
Biochemistry
Chemistry
Medicine
Cancer Oncology
Show all topics
DOI
10.1016/s2352-3026(20)30210-6
Other Formats
PDF
